Gain Therapeutics, Inc. (GANX) SEC Filings — 2025
17 SEC filings for Gain Therapeutics, Inc. (GANX) in 2025.
Filings
- Gain Therapeutics Files 8-K Report — 8-K · Dec 18, 2025
- Gain Therapeutics Files 8-K — 8-K · Nov 28, 2025
- Gain Therapeutics, Inc. 8-K Filing — 8-K · Nov 12, 2025
- Gain Therapeutics Files 8-K — 8-K · Oct 14, 2025
- Gain Therapeutics Announces Board and Compensation Changes — 8-K · Oct 9, 2025
- Gain Therapeutics Files 8-K: Details Pending — 8-K · Oct 6, 2025
- Gain Therapeutics Narrows Loss, Cash Dwindles Amid R&D Cuts — 10-Q · Aug 12, 2025
- Gain Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 17, 2025
- Gain Therapeutics Files 8-K Report — 8-K · Jun 30, 2025
- Gain Therapeutics Files 8-K on Corporate Updates — 8-K · Jun 24, 2025
- Gain Therapeutics Q1 2025: Balance Sheet Insights — 10-Q · May 14, 2025
- Gain Therapeutics Proxy Statement Filed — DEF 14A · Apr 29, 2025
- Gain Therapeutics Files 8-K — 8-K · Apr 10, 2025
- Gain Therapeutics Files 2024 10-K — 10-K · Mar 27, 2025
- Gain Therapeutics Files 8-K — 8-K · Feb 6, 2025
- Gain Therapeutics Faces Delisting Concerns — 8-K · Jan 15, 2025
- Gain Therapeutics Appoints New CMO, Director — 8-K · Jan 7, 2025